Publications
324
Citations
1,519
Est. group size
—
Recurring co-author estimate
Active years
43
Publishing since 1984
Andrés Acosta's research spans two main areas in medicine: cancer of the male reproductive and urinary systems (particularly prostate and testicular tumors), and the biology of obesity and appetite regulation. Recent work includes a clinical trial testing combination therapies for prostate cancer, laboratory studies distinguishing types of germ cell tumors, and studies linking eating behavior, gut hormones, and diet to different obesity subtypes.
Publication activity has grown substantially over the past decade, rising from single digits per year in the late 2010s to a peak of nearly 90 in 2025.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Immunophenotypic assessment of pure embryonal carcinoma and yolk sac tumour suggests that reprogramming to non‐seminoma occurs outside the spermatogonial niche
Histopathology · 2026
- Supplementary Figure S2 from Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial
2026
- Supplementary Table S1 from Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial
2026
- Data from Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial
2026
- Supplementary Table S2 from Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial
2026
- Supplementary Figure S1 from Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial
2026
- Supplementary Table S3 from Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial
2026
- Supplementary Figure S3 from Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial
2026
- 1078 PERFORMANCE OF A MACHINE-LEARNING GENE RISK SCORE FOR CALORIES TO SATIATION BIOMARKER PREDICTS RESPONSE TO PHENTERMINE-TOPIRAMATE: A REAL-WORLD RETROSPECTIVE STUDY
Gastroenterology · 2026
- Sa1784 RELATIONSHIPS BETWEEN SERUM GLUTAMIC ACID AND PARAMETERS OF ENERGY BALANCE REGULATION IN ADULTS WITH OBESITY
Gastrointestinal Endoscopy · 2026
- Sa1784 RELATIONSHIPS BETWEEN SERUM GLUTAMIC ACID AND PARAMETERS OF ENERGY BALANCE REGULATION IN ADULTS WITH OBESITY
Gastroenterology · 2026
- Sa1787 DISTINCT CALORIC INTAKE AND EATING BEHAVIOR PROFILES ACROSS OBESITY PHENOTYPES
Gastroenterology · 2026
- 849 ENTEROENDOCRINE HORMONES AND THEIR RELATIONSHIP WITH APPETITE IN ADULTS WITH OBESITY
Gastrointestinal Endoscopy · 2026
- Sa1787 DISTINCT CALORIC INTAKE AND EATING BEHAVIOR PROFILES ACROSS OBESITY PHENOTYPES
Gastrointestinal Endoscopy · 2026
- 849 ENTEROENDOCRINE HORMONES AND THEIR RELATIONSHIP WITH APPETITE IN ADULTS WITH OBESITY
Gastroenterology · 2026
- Gastroenterology×34
- Histopathology×31
- Laboratory Investigation×19
- Modern Pathology×16
- Gastrointestinal Endoscopy×14
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile